In Part II of this blog series we look at recent transactions in the arena of contract research organization, with a particular focus on private equity investing in CROs.
In one recent example, prescription drug data-mining company IMS Health acquired
Continue Reading Private Equity Opportunities in Contract Research Organizations (CROs): Part II